Dimitrios Iliopoulos

Dimitrios Iliopoulos is the Co-founder, President & CEO at Athos Therapeutics Inc since 2019. DIMITRIOS is also the Co-founder & Chairman of the Board at Attica Sciences Ltd and holds the title of Councilor at ARISTEiA. With a background in academia, business consulting, and biotechnology, Dimitrios has a strong foundation in finance, strategy, and medicine. DIMITRIOS has made significant contributions in the field of biomedicine and drug discovery, working with prestigious institutions such as UCLA Health System, Dana-Farber Cancer Institute, and Harvard Medical School. Additionally, Dimitrios holds degrees in Artificial Intelligence, Mergers & Acquisitions, Biotechnology Finance & Investing, and has expertise in financial modeling for biotech and pharma drugs.